Venus Aerospace has raised $90 million in Series B funding to develop its Rotating Detonation Rocket Engine (RDRE). The company aims to transition from hypersonic passenger jets to military applications, reflecting growing interest from defense contractors after the engine's successful tests.
Venus Aerospace has announced a $90 million Series B funding round, led by Mercury Fund with investments from Lockheed Martin Ventures and other firms. This funding will facilitate testing and design development of its Rotating Detonation Rocket Engine (RDRE).
Originally aimed at developing clean hypersonic jets, the company's focus has now shifted towards military applications. After demonstrating their engine in 2022, interest surged from defense contractors seeking advanced propulsion systems.
The RDRE functions by creating a continuous supersonic wave of combustion which reduces propellant waste. This innovative design demonstrates significant efficiency over traditional rocket engines and is being adapted for hypersonic weapons and other military needs.
Developed from concepts proposed in the mid-20th century, the RDRE has faced challenges in practical implementation. Recent advancements in 3D printing and simulation have made successful tests more feasible, highlighting a significant shift in rocket engine technology.
Venus Aerospace is set to leverage this funding to deliver reliable propulsion systems for defense and space missions. The company is actively working on translating its technological progress into operational systems for potential military clients.
β¨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors β check the original sources. How BrevFeed works β
Venus Aerospace has raised $90 million in Series B funding to develop its Rotating Detonation Rocket Engine (RDRE). The company aims to transition from hypersonic passenger jets to military applications, reflecting growing interest from defense contractors after the engine's successful tests.